A new class of weight loss drugs has already reshaped how people think about fat loss, but retatrutide is positioning itself ...
A study, published in Nature, investigated drugs such as semaglutide and tirzepatide, which have gained global attention for ...
Distinct GLP1R and GIPR variants correlated with nausea/vomiting risk, with a GIPR signal appearing tirzepatide-specific and showing markedly increased vomiting odds. New studies from 23andMe suggest ...
Research suggests GLP-1 drugs like Ozempic and Wegovy could double divorce risk, mirroring trends seen in bariatric surgery patients, experts say.
After massive weight loss, many face a challenge that is largely underdiscussed: excess skin.
Drugmakers Novo Nordisk and Eli Lilly and Company have transformed the landscape of chronic weight loss management with the ...
Experts warn that rapid weight loss from GLP-1 medications may come with an unexpected downside.
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body weight reductions of 7.72 kg and ...
Tirzepatide is linked to significant weight loss in adults with overweight or obesity who are taking weight-inducing medications, suggesting benefits even when these therapies are continued.
Recent research shows that intermittent fasting may have positive effects on testosterone levels, which could aid weight loss in women with PCOS.
GLP-1 weight loss drugs are revolutionizing physical health, but experts warn of an "Ozempic divorce boom" as shifting ...
Water fasting involves consuming only water for a set time and triggers metabolic changes like glycogen depletion and ketosis ...